Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team.

Digital asset regulation finally shifted into gear in 2025 as the US moved toward a more crypto-friendly legal framework and ...

This article, presented in the backdrop of the debates on the state of political theory in India, argues that the terms of ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

Now imagine that sensation amplified a hundredfold, and you’ve got the Guardian Angel Thrift Store experience in Fuquay-Varina, North Carolina. This isn’t your run-of-the-mill secondhand shop where ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...